A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLC.

Michael, M; Wirth, A; Ball, D L; MacManus, M; Rischin, D; Mileshkin, L; Solomon, B; McKendrick, J; Milner, A D

Michael, M; Wirth, A; Ball, D L; MacManus, M; Rischin, D; Mileshkin, L; Solomon, B; McKendrick, J; Milner, A D.

Affiliation

Michael M; The Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St, Victoria 8006, Australia. michael.michael@petermac.org

Br J Cancer ; 93(6): 652-61, 2005 Sep 19.

Article in En | MEDLINE | ID: mdl-16222311

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Non-Small-Cell Lung/drug therapy; Carcinoma, Non-Small-Cell Lung/radiotherapy; Lung Neoplasms/drug therapy; Lung Neoplasms/radiotherapy; Adult; Aged; Carcinoma, Non-Small-Cell Lung/secondary; Cisplatin/administration & dosage; Combined Modality Therapy; Female; Humans; Lung Neoplasms/pathology; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Vinblastine/administration & dosage; Vinblastine/analogs & derivatives; Vinorelbine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2005 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google